Literature DB >> 8574645

NADPH-diaphorase activity and Fos expression in brain nuclei following nitroglycerin administration.

C Tassorelli1, S A Joseph.   

Abstract

Organic nitrates are considered nitric oxide donors in that they have been shown to form nitric oxide in vitro and in vivo. Nitroglycerin is an organic nitrate which possesses peculiar activities mediated, to some extent, by the central nervous system via the noradrenergic system. Previous reports have shown that systemic nitroglycerin is able to induce Fos expression in brain nuclei which are known to contain nitric oxide synthesizing enzyme. Neuronal NADPH-diaphorase has been shown to be a nitric oxide synthase. Thus, in this study we used NADPH-diaphorase histochemistry to evaluate the distribution of Fos-immunoreactive cells within neurons which contain nitric oxide synthase. The data showed co-localization of Fos with NADPH-diaphorase activity in numerous neurons of the paraventricular and supraoptic nuclei of the hypothalamus. In the brainstem, a few neurons were doubly labeled for Fos and NADPH-diaphorase activity, but NADPH-diaphorase positive fibers and Fos-immunoreactive neurons were consistently co-distributed in the locus coeruleus, parabrachial nucleus, nucleus tractus solitarius and spinal trigeminal nucleus caudalis. These findings demonstrate that nitroglycerin administration activates a selective group of neurons which are a source of nitric oxide or which are in close proximity with neuronal processes containing nitric oxide synthase, and suggest that the nitric oxide synthase synthesizing pathway may be involved at various levels in the central effect of nitroglycerin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8574645     DOI: 10.1016/0006-8993(95)00732-6

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  13 in total

1.  Triptan-induced enhancement of neuronal nitric oxide synthase in trigeminal ganglion dural afferents underlies increased responsiveness to potential migraine triggers.

Authors:  Milena De Felice; Michael H Ossipov; Ruizhong Wang; Gregory Dussor; Josephine Lai; Ian D Meng; Juliana Chichorro; John S Andrews; Suman Rakhit; Shawn Maddaford; David Dodick; Frank Porreca
Journal:  Brain       Date:  2010-07-13       Impact factor: 13.501

Review 2.  CGRP and migraine: could PACAP play a role too?

Authors:  Eric A Kaiser; Andrew F Russo
Journal:  Neuropeptides       Date:  2013-10-23       Impact factor: 3.286

3.  Expression and localization of c-Fos and NOS in the central nerve system following esophageal acid stimulation in rats.

Authors:  Xiao-Wei Shuai; Peng-Yan Xie
Journal:  World J Gastroenterol       Date:  2004-08-01       Impact factor: 5.742

Review 4.  Migraine: where and how does the pain originate?

Authors:  Karl Messlinger
Journal:  Exp Brain Res       Date:  2009-03-14       Impact factor: 1.972

Review 5.  Animal migraine models for drug development: status and future perspectives.

Authors:  Inger Jansen-Olesen; Peer Tfelt-Hansen; Jes Olesen
Journal:  CNS Drugs       Date:  2013-12       Impact factor: 5.749

Review 6.  Dialysis headache.

Authors:  Ana Luisa de Lima Antoniazzi; Alexandre Pinto Corrado
Journal:  Curr Pain Headache Rep       Date:  2007-08

7.  Soluble guanylyl cyclase is a critical regulator of migraine-associated pain.

Authors:  Manel Ben Aissa; Alycia F Tipton; Zachariah Bertels; Ronak Gandhi; Laura S Moye; Madeline Novack; Brian M Bennett; Yueting Wang; Vladislav Litosh; Sue H Lee; Irina N Gaisina; Gregory Rj Thatcher; Amynah A Pradhan
Journal:  Cephalalgia       Date:  2017-10-12       Impact factor: 6.292

8.  Neuronal complexity is attenuated in preclinical models of migraine and restored by HDAC6 inhibition.

Authors:  Zachariah Bertels; Harinder Singh; Isaac Dripps; Kendra Siegersma; Alycia F Tipton; Wiktor D Witkowski; Zoie Sheets; Pal Shah; Catherine Conway; Elizaveta Mangutov; Mei Ao; Valentina Petukhova; Bhargava Karumudi; Pavel A Petukhov; Serapio M Baca; Mark M Rasenick; Amynah A Pradhan
Journal:  Elife       Date:  2021-04-15       Impact factor: 8.140

9.  Heme oxygenase-1 induction and organic nitrate therapy: beneficial effects on endothelial dysfunction, nitrate tolerance, and vascular oxidative stress.

Authors:  Andreas Daiber; Matthias Oelze; Philip Wenzel; Franziska Bollmann; Andrea Pautz; Hartmut Kleinert
Journal:  Int J Hypertens       Date:  2012-03-07       Impact factor: 2.420

10.  Changes in calcitonin gene-related peptide (CGRP) receptor component and nitric oxide receptor (sGC) immunoreactivity in rat trigeminal ganglion following glyceroltrinitrate pretreatment.

Authors:  Kristin Seiler; Judith I Nusser; Jochen K Lennerz; Winfried L Neuhuber; Karl Messlinger
Journal:  J Headache Pain       Date:  2013-09-03       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.